Document is current
Any future updates will be listed below
-
Authors
Angajala, Anusha
Raymond, Hughley
Muhammad, Aliyu
Uddin Ahmed, Md Shakir
Haleema, Saadia
Haque, Monira
Wang, Honghe
Campbell, Moray
Martini, Rachel
Karanam, Balasubramanian
Kahn, Andrea G.
Bedi, Deepa
Davis, Melissa
Tan, Ming
Dean-Colomb, Windy
Yates, Clayton
- License Information
-
More Information
Article History
Received: 30 July 2022
Accepted: 7 December 2022
First Online: 22 December 2022
Competing interests
: CY is a shareholder in Riptide Biosciences and is a consultant for QED Therapeutics, Riptide Biosciences, and Amgen. There has been no financial support for this work that could have influenced its outcome. All other authors do not have competing interests.
